InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Flagship Ventures Fund V General Partner LLC. Insider active across 3 companies, notably Codiak BioSciences, Inc.. In total, 5 disclosures have been logged. Split: 1 buy · 2 sells. Total volume traded: €3m. History available since 24 May 2023. The latest transaction was filed on 11 August 2023 (U). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Flagship Ventures Fund V General Partner LLC is a declarant linked to Sigilon Therapeutics, Inc., Sana Biotechnology, Inc. and Codiak BioSciences, Inc. The record shows 5 filings in total, and across the 5 sampled filings, the period runs from 2022-09-16 to 2023-08-15, with aggregate sales of EUR 2951142 and a modal transaction nature of U.